• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Parvus and Genentech to develop treatment options in gastroenterology pharmaceutical-technology
    May 22, 2019
    Biopharmaceutical firm Parvus Therapeutics has signed a worldwide collaboration and licence agreement with Genentech to develop, manufacture and commercialise therapeutics for inflammatory bowel disease (IBD), autoimmune liver diseases (ALD) and coeliac d

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service